The/DT
number/NN
of/IN
glucocorticoid/NN
receptors/NNS
in/IN
peripheral/JJ
human/JJ
lymphocytes/NNS
is/VBZ
elevated/VBN
by/IN
a/DT
zinc/NN
containing/VBG
trace/NN
element/NN
preparation/NN
./.

A/DT
trace/NN
element/NN
preparation/NN
(/(
Beres/NN
Drops/NN
Plus/NN
,/,
BDP/NN
)/)
elevates/VBZ
the/DT
number/NN
of/IN
glucocorticoid/NN
receptors/NNS
(/(
gcR/NN
)/)
in/IN
peripheral/JJ
lymphocytes/NNS
isolated/VBN
both/CC
from/IN
healthy/JJ
blood/NN
donors/NNS
and/CC
rheumatoid/JJ
arthritis/NN
patients/NNS
./.
=====
This/DT
enhancement/NN
by/IN
BDP/NN
was/VBD
found/VBN
either/CC
for/IN
constitutive/JJ
expression/NN
of/IN
gcRs/NNS
or/CC
in/IN
experiments/NNS
when/WRB
the/DT
lymphocytes/NNS
were/VBD
stimulated/VBN
by/IN
interleukin/NN
(/(
IL/NN
)/)
-6/CD
./.
=====
There/EX
was/VBD
no/DT
significant/JJ
effect/NN
of/IN
BDP/NN
on/IN
IL-1/NN
and/CC
tumour/NN
necrosis/NN
factor/NN
alpha/NN
(/(
TNF/NN
alpha/NN
)/)
-induced/JJ
changes/NNS
of/IN
gcRs/NNS
./.
=====
The/DT
effect/NN
of/IN
BDP/NN
was/VBD
greatly/RB
dependent/JJ
on/IN
the/DT
presence/NN
of/IN
Zn++/NN
ions/NNS
in/IN
the/DT
preparation/NN
,/,
since/IN
the/DT
augmenting/VBG
effect/NN
was/VBD
abolished/VBN
if/IN
BDP/NN
did/VBD
not/RB
contain/VB
zinc/NN
./.